China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project (CORNERSTONE)

P

Peking University

Status

Enrolling

Conditions

Prurigo Nodularis
Atopic Dermatitis Eczema

Study type

Observational

Funder types

Other

Identifiers

NCT05316805
PKU202108

Details and patient eligibility

About

In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with type 2 inflammatory skin diseases, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases and help patients with type 2 inflammatory skin diseases.

Enrollment

100,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients from the medical units that has passed the data review of the National Clinical Center for Skin and Immune Diseases (see the study sites for data collection for details);
  2. patients diagnosed with type 2 inflammatory skin diseases (dermatitis/eczema, urticaria, pemphigoid, prurigo nodularis).

Exclusion criteria

  1. patients who fail to provide informed consent form;
  2. patients who cannot complete the questionnaire independently or under the guidance of investigators

Trial contacts and locations

1

Loading...

Central trial contact

Yang Wang, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems